Abstract: Embodiments of the present disclosure relate to methods and apparatuses for coverage extension and wireless communication. According to some embodiments of the disclosure, a method may include: receiving from a base station (BS) a message comprising an indication that a drone-based relay or vehicle-based relay is supported by the BS, wherein the mobile terminal is allowed to serve as a relay node between the BS and a user equipment (UE); and in response to receiving the indication indicating that a drone-based relay or vehicle-based relay is supported by the BS, performing a random access procedure with the BS. In addition, the mobile terminal may report the assistant information, e.g., the remaining power information, to the BS.

Abstract: A method for performing random access includes: performing a 2-step RA procedure with a BS (S401); receiving a fallback RAR from BS (S404); performing a 4-step RA procedure with BS (S405); and associating a 2-step RA information of the 2-step RA procedure with a 4-step RA information of the 4-step RA procedure (S407).

Abstract: The present disclosure provides a method for controlling an amount of silicon added to ductile cast iron, a method for casting ductile cast iron, and a cast product, which relate to the technical fields of metallurgical and cast iron alloys. The method for controlling an amount of silicon added to ductile cast iron includes smelting ductile cast iron using scrap steel as a raw material. After the scrap steel is melted into molten iron, a copper alloy is added so that the molten iron has a copper equivalent of 0.8% to 1.0%, wherein the copper equivalent is controlled by formula (II). Then, ferrosilicon is added so that the content of silicon added to the molten iron satisfies formula (I).

Abstract: This document provides methods and materials involved in killing HIV infected cells (e.g., CD4 T cells). For example, methods and materials for using one or more Bcl-2 inhibitors (e.g., ABT-199) alone or in combination with one or more agents capable of reactivating HIV (e.g., latency reversing agent) to kill HIV infected cells (e.g., CD4 T cells) are provided.

Abstract: Disclosed are methods and apparatus for artificial intelligence (AI) application in radio access network (RAN). One embodiment of the subject application provides a method performed by a training host (or a wireless network node including a training host) includes receiving a request associated with a wireless network activity, identifying a primary processing model for accomplishing the wireless network activity, and transmitting first information associated with the primary processing model to a second wireless network node to accomplish the wireless network activity, herein the first wireless network node is capable of identifying the primary processing model from a plurality of processing models to accomplish the wireless network activity.

Abstract: Embodiments of the present application relate to methods and apparatuses for multicast and broadcast services (MBS). An exemplary method performed by a node of a wireless network to provide a multicast and broadcast service (MBS) associated with a user equipment (UE) of the wireless network may include: determining whether to activate or deactivate a point-to-point (PTP) mode to provide the MBS to the UE; and transmitting a data transmission indication via a user plane protocol of a network interface in the wireless network to activate or deactivate the PTP mode. Embodiments of the present application can support more efficient dynamic switching between PTP mode and point-to-multipoint (PTM) mode for MBS and/or distinguish new transmission data and retransmission data for MBS.

Abstract: The present application relates to a method and an apparatus for performing a handover procedure. One embodiment of the subject application provides a method, which includes: receiving a configuration signaling including first configuration information or second configuration information; determining a first target primary cell (PCell) based on the configuration signaling; and performing a handover procedure to the first target PCell.

Abstract: This document provides methods and materials involved in killing HIV infected cells (e.g., CD4 T cells). For example, methods and materials for using one or more Bcl-2 inhibitors (e.g., ABT-199) alone or in combination with one or more agents capable of reactivating HIV (e.g., latency reversing agent) to kill HIV infected cells (e.g., CD4 T cells) are provided.

Abstract: This document provides methods and materials involved in killing HIV infected cells (e.g., CD4 T cells). For example, methods and materials for using one or more Bcl-2 inhibitors (e.g., ABT-199) alone or in combination with one or more agents capable of reactivating HIV (e.g., latency reversing agent) to kill HIV infected cells (e.g., CD4 T cells) are provided.